Top news of the week: 10.03.2022.
Career And Jobs
COVID-19 Changed the Biopharma Industry - and There's No Going Back
From artificial intelligence breakthroughs to at-home genetic testing, here are some ways COVID-19 has changed the biopharma industry and what we may see in the near future.
Three More Biopharma Companies Shuffle Executive Deck
Three biotech firms announced a change in leadership recently, led by Pardes Biosciences, followed by HUTCHMED and BeiGene. Read the details below.
ABCV Biopharma Rallies Active Herbal Ingredients Against Cancer, MDD & ADHD
ABVC Biopharma, based in California, has programs in Phase II trials to treat major depressive disorder, adult attention deficit hyperactivity disorder and myelodysplastic syndrome.
New Atlas Fund will Pump $450M Fund into Biotech
Atlas Venture raised $450 million at the close of its thirteenth fundraising activity to support efforts to create and invest in new biotech firms that address many unmet patient needs.
BRAIN Biotech AG: Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG
DGAP-News: BRAIN Biotech AG / Key word(s): AGM/EGM09.03.2022 / 16:00 The issuer is solely responsible for the content of this announcement.Resolutions of the Annual General Meeting for the ...
Biotech Hub Holly Springs Welcomes Global Leader Amgen to its Family of Life Sciences Companies
Biotech Hub Holly Springs Welcomes Global Leader Amgen to its Family of Life Sciences Companies
GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH CAROLINA
To achieve this goal, Amgen will work with businesses, educational institutions, and training partners to better develop, retain and advance diverse talent, focusing on Black …
AVM Biotechnology Expands C-Suite in Anticipation of 2023 Commercialization Efforts
Developing the Promise of AVM0703 with an Accomplished Leadership TeamSEATTLE--(BUSINESS WIRE)--#Leukemia--AVM Biotechnology, a clinical stage company developing AVM0703, a small molecule ...